Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid LeukemiaIvana Gojo, Douglas D. Ross, Hong‐Bin Fang et al.|Clinical Cancer Research|2013Cited by 49